mRNA-4157,Pembrolizumab
Moderna,Merck
['moderna']
aacr 2023: cancer vaccine trial results elicit reactions from 'indisputable' to 'cautious optimism' #biotech #pharma #aacr23 
Biopharma’s trusted news source. Lynn Yoffee, Jennifer Boggs, Karen Carey, Anette Breindl, Lee Landenberger, Randy Osborne, Mari Serebrov, Caroline Richards